Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Targeting deadly drug-resistant acinetobacter infections
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms
Subscribe To Our Newsletter & Stay Updated